Serological Protection Rates against TBEV Infection in Blood Donors from a Highly Endemic Region in Southern Germany.
Gerhard DoblerKathrin EuringerKlaus KaierJohannes P BordePublished in: Vaccines (2023)
In this study, we present new findings on a highly endemic region in southern Germany. Additionally, we present current data regarding the serological TBEV protection rates in the Ortenaukreis in southern Germany and compare these with a dataset published by the RKI, which is based on vaccination reports of the primary care providers and health care insurers, and with a self-reporting study conducted by a vaccine manufacturer. Our results significantly exceed the official numbers of average active vaccination status by 23.2% for females and by 21% for males. This might indicate an even longer persistence of TBE-vaccination-induced antibody titers than previously assumed.